Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Health Care Stocks Technical Data -- Research on St Jude Medical, EnteroMedics, Zimmer Holdings, and Varian Medical Systems

LONDON, April 14, 2014 /PRNewswire/ --

On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89%, to finish the day at 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 644.74, down 1.07%, and the same has fallen by 2.21% in the previous three trading sessions. Investor-Edge has initiated coverage on the following equities: St Jude Medical Inc. (NYSE: STJ), EnteroMedics Inc. (NASDAQ: ETRM), Zimmer Holdings Inc. (NYSE: ZMH) and Varian Medical Systems Inc. (NYSE: VAR). Free technical research on STJ, ETRM, ZMH and VAR can be downloaded upon signing up at:

http://www.investor-edge.com/1179-register

St Jude Medical Inc.'s stock finished the Friday's session 0.88% lower at $61.64. A total of 1.78 million shares were traded, which is below its three months average volume of 2.24 million shares. The stock traded between $61.47 and $62.85 during the session. Shares of the company traded at a PE ratio of 16.31. St Jude Medical Inc.'s stocks have declined 2.05% in the previous three trading sessions, 6.61% in the last three months, and 0.50% on YTD basis. The company shares are trading above their 200-day moving average. St Jude Medical Inc.'s 50-day moving average of $65.36 is above its 200-day moving average of $58.22. Moreover, shares of the company have a Relative Strength Index of 33.54. Sign up today to read free research on STJ at:

http://www.investor-edge.com/1179-STJ-.pdf

On Friday, Shares in EnteroMedics Inc. fluctuated between $1.62 and $1.75 before ending session 2.98% lower at $1.63. EnteroMedics Inc.'s stock reported a trading volume of 1.59 million shares, as compared with its three months average volume of 1.22 million shares. EnteroMedics Inc.'s shares have plummeted 4.68% in the previous three trading sessions, 29.44% in the last three months and 20.10% on YTD basis. The stock is trading above its 200-day moving averages of $1.62. Additionally, the stock has an RSI of 29.02. Sign up today to read free research on ETRM at:

http://www.investor-edge.com/1179-ETRM-.pdf

Zimmer Holdings Inc.'s stock declined 1.26%, to close the day at $91.50. The stock recorded a trading volume of 1.21 million shares as compared with its three months average volume of 1.14 million shares. The stock oscillated between $91.45 and $93.06 during the trading session. Shares of the company traded at a PE ratio of 15.93. Zimmer Holdings Inc.'s shares have fallen by 2.50% in the previous three months, 5.48% in the last one month and 1.81% on YTD basis. The stock is trading above its 200-day moving average. Zimmer Holdings Inc.'s 50-day moving average of $94.88 is above its 200-day moving average of $88.45. Moreover, shares of the company have an RSI of 39.78. Sign up today to read free research on ZMH at:

http://www.investor-edge.com/1179-ZMH-.pdf

On Friday, Shares in Varian Medical Systems Inc. registered a trading volume of 0.80 million shares, as compared with its three months average volume of 0.69 million shares. The stock ended the day at $80.06, down 1.26% and at an intraday range of $80.00 and $81.40. Varian Medical Systems Inc.'s shares have lost 4.62% in the previous three trading sessions, 5.53% in the last one month while the same has gained 3.05% on YTD basis. The company stock is trading above its 200-day moving average of $76.89. Furthermore, the shares of the company have an RSI of 32.63. Sign up today to read free research on VAR at:

http://www.investor-edge.com/1179-VAR-.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.